Pain Reform Ltd - Understand $prfx stock

$PRFX Market Cap: $1.182 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$0.00

TTM

Gross Margin

Net Earnings

-$17.67M

TTM

Current Assets

$2.992M

Q2 2024

Current Liabilities

$4.891M

Q2 2024

Current Ratio

61.17%

Q2 2024

Total Assets

$3.107M

Q2 2024

Total Liabilities

$5.148M

Q2 2024

Book Value

-$2.041M

Q2 2024

Cash

$2.783M

Q2 2024

P/E

-0.06687

Nov 15, 2024 EST

Free Cash Flow

-$11.38M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Cost Of Revenue
Gross Profit
Gross Profit Margin

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017
Selling, General & Admin	$1.676M	$4.447M	$4.348M	$1.320M	$550.0K	$280.0K	$380.0K
YoY Change	-62.31%	2.28%	229.39%	140.0%	96.43%	-26.32%
% of Gross Profit
Research & Development	$6.035M	$4.422M	$2.860M	$350.0K	$140.0K	$220.0K	$500.0K
YoY Change	36.48%	54.62%	717.14%	150.0%	-36.36%	-56.0%
% of Gross Profit
Depreciation & Amortization	$15.00K	$15.00K	$7.000K	$0.00	$0.00	$0.00
YoY Change	0.0%	114.29%
% of Gross Profit
Operating Expenses	$7.711M	$4.422M	$7.208M	$1.670M	$690.0K	$500.0K	$880.0K
YoY Change	74.38%	-38.65%	331.62%	142.03%	38.0%	-43.18%
Operating Profit	-$9.584M	-$8.869M	-$7.208M	-$1.671M
YoY Change	8.06%	23.04%	331.36%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017
Interest Expense	$408.0K	$99.00K	-$22.00K	-$990.0K	-$540.0K	-$330.0K	-$240.0K
YoY Change	312.12%	-550.0%	-97.78%	83.33%	63.64%	37.5%
% of Operating Profit
Other Income/Expense, Net	$248.0K	$86.00K	-$10.00K	-$1.170M	-$50.00K	$0.00	$0.00
YoY Change	188.37%	-960.0%	-99.15%	2240.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017
Pretax Income	-$9.336M	-$8.783M	-$7.240M	-$3.830M	-$1.280M	-$830.0K	-$1.120M
YoY Change	6.3%	21.31%	89.03%	199.22%	54.22%	-25.89%
Income Tax	$8.000K	$9.000K	$6.000K	$220.0K
% Of Pretax Income
Net Earnings	-$9.344M	-$8.792M	-$7.246M	-$4.050M	-$1.280M	-$830.0K	-$1.120M
YoY Change	6.28%	21.34%	78.91%	216.41%	54.22%	-25.89%
Net Earnings / Revenue
Basic Earnings Per Share	-$7.14	-$0.82	-$0.74	-$1.25
Diluted Earnings Per Share	-$7.14	-$0.82	-$738.5K	-$1.250M	-$143.7K	-$93.15K	-$125.7K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017
Cash & Short-Term Investments	$8.026M	$4.096M	$16.54M	$15.68M	$940.0K	$40.00K	$190.0K
YoY Change	95.95%	-75.23%	5.47%	1568.09%	2250.0%	-78.95%
Cash & Equivalents	$8.026M	$4.096M	$16.54M	$15.68M	$940.0K	$40.00K	$190.0K
Short-Term Investments
Other Short-Term Assets	$1.728M	$8.133M	$2.265M	$2.060M	$10.00K	$20.00K	$10.00K
YoY Change	-78.75%	259.07%	9.95%	20500.0%	-50.0%	100.0%
Inventory
Prepaid Expenses
Receivables	$45.00K	$55.00K	$218.0K	$50.00K	$20.00K	$30.00K	$20.00K
Other Receivables	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Total Short-Term Assets	$9.799M	$12.28M	$19.02M	$17.79M	$970.0K	$80.00K	$210.0K
YoY Change	-20.23%	-35.42%	6.91%	1734.02%	1112.5%	-61.9%
Property, Plant & Equipment	$131.0K	$44.00K	$53.00K	$10.00K		$0.00	$0.00
YoY Change	197.73%	-16.98%	430.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets				$0.00	$190.0K	$0.00
YoY Change				-100.0%
Total Long-Term Assets	$131.0K	$44.00K	$53.00K	$10.00K	$190.0K	$0.00	$0.00
YoY Change	197.73%	-16.98%	430.0%	-94.74%
Total Assets	$9.930M	$12.33M	$19.07M	$17.80M	$1.160M	$80.00K	$210.0K
YoY Change
Accounts Payable	$221.0K	$209.0K	$136.0K	$720.0K	$0.00	$0.00	$60.00K
YoY Change	5.74%	53.68%	-81.11%			-100.0%
Accrued Expenses	$2.189M	$855.0K	$621.0K	$240.0K	$170.0K	$20.00K
YoY Change	156.02%	37.68%	158.75%	41.18%	750.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$1.030M	$0.00	$0.00
YoY Change				-100.0%
Long-Term Debt Due				$0.00	$5.140M	$0.00
YoY Change				-100.0%
Total Short-Term Liabilities	$2.410M	$1.064M	$757.0K	$960.0K	$6.340M	$20.00K	$140.0K
YoY Change	126.5%	40.55%	-21.15%	-84.86%	31600.0%	-85.71%
Long-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$4.520M	$3.710M
YoY Change					-100.0%	21.83%
Other Long-Term Liabilities	$281.0K	$243.0K	$234.0K	$220.0K	$450.0K	$0.00
YoY Change	15.64%	3.85%	6.36%	-51.11%
Total Long-Term Liabilities	$281.0K	$243.0K	$234.0K	$220.0K	$450.0K	$4.520M	$3.710M
YoY Change	15.64%	3.85%	6.36%	-51.11%	-90.04%	21.83%
Total Liabilities	$2.691M	$1.307M	$991.0K	$1.180M	$6.790M	$4.540M	$3.840M
YoY Change	105.89%	31.89%	-16.02%	-82.62%	49.56%	18.23%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020
Basic Shares Outstanding	1.309M shares	10.66M shares	9.812M shares	3.244M shares
Diluted Shares Outstanding	1.309M shares	10.66M shares	9.812M shares	3.244M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $1.1818 Million

About PainReform Ltd

PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.

Industry: Pharmaceutical Preparations Peers: Scinai Immunotherapeutics Ltd PolyPid Ltd Redhill Biopharma Ltd